Inactive Instrument
Mazorro Resources Inc. Stock Deutsche Boerse AG
Stocks
CA5788691098
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| Market Cap | 9.22M 7.91M 7.39M 6.78M 12.75M 882M 12.96M 87.18M 34.14M 442M 34.63M 33.88M 1.46B | P/E 2020 |
-1.43x | P/E 2021 | -1.33x |
|---|---|---|---|---|---|
| Enterprise Value | 7.45M 6.39M 5.97M 5.47M 10.29M 712M 10.46M 70.41M 27.57M 357M 27.97M 27.36M 1.18B | EV / Sales 2020 |
-
| EV / Sales 2021 | - |
| Free-Float |
100% | Yield 2020 * |
-
| Yield 2021 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Derek Theriault
PRN | Corporate Officer/Principal | - | - |
Steeve Néron
COO | Chief Operating Officer | - | 01/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Norton
CHM | Chairman | 65 | 28/05/2021 |
| Director/Board Member | 70 | 17/09/2020 | |
Catherine Auld
BRD | Director/Board Member | - | 28/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | -1.58% | -11.99% | -5.56% | 13.19B | |
| -0.46% | -3.30% | -34.03% | -57.25% | 4.9B | |
| +0.49% | -2.32% | +2.09% | +0.14% | 4.91B | |
| -1.73% | -1.61% | +1.54% | -27.87% | 4.1B | |
| -0.59% | -2.91% | -25.50% | +3.09% | 3.53B | |
| -0.97% | -0.46% | -12.31% | +14.41% | 3.38B | |
| +3.46% | -1.39% | -6.55% | -5.34% | 3.4B | |
| -1.46% | -1.95% | -17.15% | -17.10% | 2.44B | |
| -5.02% | -8.42% | -6.05% | -14.87% | 1.64B | |
| Average | -0.64% | -2.73% | -12.22% | -12.26% | 4.61B | |
| Weighted average by Cap. | -0.13% | -2.23% | -12.39% | -11.86% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.48M -22.71M -21.21M -19.46M -36.59M -2.53B -37.19M -250M -97.99M -1.27B -99.41M -97.25M -4.2B | -52.18M -44.76M -41.79M -38.34M -72.1M -4.99B -73.29M -493M -193M -2.5B -196M -192M -8.27B |
| Net Debt | -501K -429K -401K -368K -692K -47.85M -703K -4.73M -1.85M -24M -1.88M -1.84M -79.35M | -1.77M -1.52M -1.42M -1.3M -2.45M -170M -2.49M -16.77M -6.57M -85.05M -6.66M -6.52M -281M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
